Reasons for Failure of Antifungal-lock Therapy with Caspofungin: Need for Higher Concentrations | Zendy

Rana İşgüder | Zendy; Gökhan Ceylan | Zendy; Özlem Saraç Sandal | Zendy; Ferhat Sarı | Zendy; Gamze Gülfidan | Zendy; Bengü Demirağ | Zendy; Hasan Ağın | Zendy; İlker Devrim | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Reasons for Failure of Antifungal-lock Therapy with Caspofungin: Need for Higher Concentrations

Author(s) -

Rana İşgüder,

Gökhan Ceylan,

Özlem Saraç Sandal,

Ferhat Sarı,

Gamze Gülfidan,

Bengü Demirağ,

Hasan Ağın,

İlker Devrim

Publication year - 2017

Publication title -

turkish journal of pediatric emergency and intensive care medicine

Language(s) - English

Resource type - Journals

eISSN - 2148-7332

pISSN - 2146-2399

DOI - 10.4274/cayd.83792

Subject(s) - caspofungin , antifungal , lock (firearm) , intensive care medicine , echinocandin , medicine , microbiology and biotechnology , biology , voriconazole , fluconazole , engineering , mechanical engineering

Antifungal-lock therapy (AfLT) has arrived as an investigational approach for preventing catheter removal with limited clinical evidence of its efficiency. The principle of AfLT consists of catheter lumen replenishment by a selected antimicrobial agent and then locking it for an alternative treatment to eradicate the microbes embedded in endoluminal biofilms. Herein, we report a pediatric hematology-oncology patient with Candida parapsilosis-related central venous access device infection in which catheter removal was performed despite the systemic and intraluminal caspofungin treatment. For now, we recommend higher doses of caspofungin for AfLT especially in Candida parapsilosis-related catheter infections

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research